NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Canopy Growth Corporation (“Canopy” or “the Company”) (NASDAQ: CGC) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Can ...

Core Viewpoint - Robbins LLP has initiated a class action lawsuit on behalf of investors who purchased Canopy Growth Corporation (CGC) securities between May 30, 2024, and February 6, 2025, alleging that the company misled investors regarding its cost reduction measures and financial health [1][2]. Group 1: Allegations Against Canopy Growth Corporation - The lawsuit claims that Canopy Growth Corporation failed to disclose significant costs associated with the production of Claybourne pre-rolled joints and indirect costs related to Storz & Bickel vaporizer devices, which negatively impacted the company's gross margins and overall financial results [2]. - It is alleged that the company overstated the effectiveness of its cost reduction measures while downplaying issues related to its gross margins [2]. Group 2: Financial Impact and Stock Performance - On February 7, 2025, Canopy announced disappointing financial results attributed to the costs from the Claybourne product launch and increased indirect costs, leading to a 27.24% drop in share price, closing at $2.02 [3]. Group 3: Class Action Participation - Shareholders interested in serving as lead plaintiffs in the class action must contact Robbins LLP before June 3, 2025, although participation is not required to be eligible for recovery [4].

Core Viewpoint - A class action lawsuit has been filed against Canopy Growth Corporation for allegedly misleading investors regarding its cost reduction measures and financial performance during a specified period [1][2]. Allegations - The lawsuit claims that Canopy Growth Corporation failed to disclose significant costs associated with the production of Claybourne pre-rolled joints and indirect costs related to Storz & Bickel vaporizer devices, which negatively impacted the company's gross margins and overall financial results [2]. - It is alleged that the company overstated the effectiveness of its cost reduction measures while downplaying issues related to its gross margins [2]. Financial Impact - On February 7, 2025, Canopy announced disappointing financial results attributed to the costs from the Claybourne product launch and increased indirect costs, leading to a 27.24% drop in share price, closing at $2.02 [3]. Class Action Participation - Shareholders may be eligible to participate in the class action against Canopy Growth Corporation, with a deadline for lead plaintiff applications set for June 3, 2025 [4]. Company Background - Robbins LLP is noted as a leader in shareholder rights litigation, focusing on helping shareholders recover losses and improve corporate governance since 2002 [5].

Toronto, Ontario--(Newsfile Corp. - March 27, 2025) - Canadian Gold Corp. (TSXV: CGC) ("Canadian Gold" or the "Company") is pleased to announce that it has closed its non-brokered financing previously announced on March 10, 2025. The Company issued 8,823,529 charity flow-through shares (the "Charity FT Shares") at a price of $0.28 per Charity FT Share and 2,941,176 common share units (the "Share Units") at a price of $0.17 per Share Unit for aggregate gross proceeds to the Company of approximately $3 milli ...

Core Insights - Canadian cannabis stocks are under close observation due to their ties to the expanding U.S. market, which could reach $72 billion by 2030 [1][21] - The U.S. Department of Health and Human Services has recommended rescheduling cannabis to Schedule III, increasing optimism for federal reform [1] - Key Canadian companies with U.S. exposure include Tilray Brands, Canopy Growth Corporation, and Village Farms International, each with distinct strategies and financial positions [3][21] Group 1: Tilray Brands, Inc. (TLRY) - Tilray is a prominent player in the global cannabis market, focusing on strategic partnerships and acquisitions in the U.S. despite federal restrictions [4][6] - The company reported revenue of $177 million, a 34% year-over-year increase, driven by beverage and wellness sales, while cannabis revenue grew modestly [8] - Tilray's long-term strategy aims for profitability and a strong position in cannabis, wellness, and beverages, with a $20 million share repurchase program indicating confidence in future performance [7][9] Group 2: Canopy Growth Corporation (CGC) - Canopy Growth, once the largest cannabis stock in Canada, is now focused on profitability and capturing U.S. market share through investments in Acreage Holdings and Wana Brands [9][11] - The company reported revenue of $62 million, a 21% year-over-year decline, with net losses of $216 million, although it showed improvement in U.S. CBD and wellness divisions [13] - Canopy is restructuring to save $100 million annually and is simplifying its business model to focus on high-growth segments [14][15] Group 3: Village Farms International, Inc. (VFF) - Village Farms operates in both cannabis and produce industries, providing a buffer against cannabis market volatility [15][16] - The company reported revenue of $71 million, with cannabis sales contributing $29 million, and a net loss of $9.5 million, which was narrower than previous losses [18][20] - Village Farms is committed to cost discipline and has a strong balance sheet, ending the quarter with over $20 million in cash and minimal debt, positioning it well for future growth [20]

Core Insights - Wana Brands has launched its hemp-derived Delta-9 THC gummies in Texas, marking the 22nd state for product availability, emphasizing the company's commitment to safe and reliable cannabis products [1][2] - The expansion into Texas aligns with the evolving cannabis landscape in the state, allowing Wana to meet consumer demand through strategic retail placements [2] - Wana Brands prioritizes quality and safety, with all products undergoing rigorous third-party testing for potency, purity, and contaminants [3] Company Strategy - The expansion beyond the Wanderous marketplace is a key growth strategy for Wana, aiming to capture market share by increasing product accessibility at local retail locations [4] - Wana's mission focuses on enhancing lives through plant-powered products and providing consumers with the education needed for informed choices [4] Company Background - Wana is recognized as North America's most trusted edibles brand, with a presence in multiple U.S. states, Puerto Rico, and Canada, founded in 2010 [5] - Canopy USA, the parent company of Wana, holds a non-controlling interest in Canopy Growth and is strategically positioned in high-potential segments of the U.S. cannabis market [6]

Strategic Partnership Increases Consumer Availability for Premium Cannabis BeveragesBOULDER, Colo., March 12, 2025 /PRNewswire/ -- Wana Brands, North America's leading edibles provider and a subsidiary of Canopy USA LLC ("Canopy USA"), today announced that Wana Beverages are now available at Total Wine & More locations nationwide, highlighting the increasing consumer demand for health-conscious, zero-proof alcohol alternatives. Wana Beverages, a hemp-infused line of ready-to-drink sparkling beverages cra ...

Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud or unlawful business practices by Canopy Growth Corporation and its officers or directors [1] Financial Performance - On February 7, 2025, Canopy Growth Corporation reported its financial results for Q3 of fiscal year 2025, showing year-over-year declines in both net revenue and gross margin, leading to a wider-than-expected net loss for the quarter [2] - Following the financial report, Canopy's stock price dropped by $0.76 per share, or 27.34%, closing at $2.02 per share on the same day [2]

Core Viewpoint - Canopy Growth Corp.'s stock experienced a significant decline of 9%, reaching an all-time low, following the announcement of a plan to sell up to $200 million of its stock [1] Group 1: Stock Performance - The stock of Canopy Growth Corp. fell by 9% [1] - This decline resulted in the stock reaching an all-time low [1] Group 2: Stock Offering Details - The company plans to sell up to $200 million of its stock [1] - This stock offering would nearly double the dollar amount of its stock currently trading on the Nasdaq and the Toronto Stock Exchange, given the company's market capitalization of approximately $240 million [1]

Core Viewpoint - Canopy Growth Corporation has launched a new at-the-market equity program allowing the issuance and sale of up to US$200 million of common shares to support corporate purposes, including debt repayment and strategic acquisitions [1][2]. Group 1: ATM Program Details - The ATM Program enables Canopy Growth to issue and sell common shares in public offerings in the U.S. and Canada, with sales conducted at prevailing market prices [1]. - The program will remain effective until the earlier of the sale of all shares, regulatory notice of cessation of effectiveness, or July 5, 2026, unless terminated earlier [3]. - The offering is qualified by a prospectus supplement filed with Canadian and U.S. securities regulators [4]. Group 2: Use of Proceeds - Net proceeds from the ATM Program will be utilized for investments in businesses, potential acquisitions, working capital, and general corporate purposes, including a US$100 million optional prepayment under the existing credit agreement [2]. Group 3: Company Overview - Canopy Growth is a leading cannabis company focused on improving lives through cannabis products, with operations in Canada, Germany, Poland, and Australia [6][7]. - The company has established a comprehensive ecosystem to capitalize on the U.S. THC market through non-controlling interests in Canopy USA, which includes ownership stakes in Acreage Holdings and Wana Brands [8].